TAR-200 achieved an 82% tumor elimination rate in high-risk non-muscle-invasive bladder cancer patients resistant to previous treatments. The device releases gemcitabine into the bladder over three ...
Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback